Structure Therapeutics Inc. Increase (Decrease) in Deferred Income Taxes
Structure Therapeutics Inc. (GPCR) reported Increase (Decrease) in Deferred Income Taxes of -$121.00 thousand for the 6-month period ending 2022-06-30, per its 10-Q/A filed 2023-11-17.
Discontinued › Cash Flow
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2023-11-17
- Structure Therapeutics Inc. increase (decrease) in deferred income taxes for the quarter ending 2022-06-30 was -$115.00K.
- Structure Therapeutics Inc. increase (decrease) in deferred income taxes for the quarter ending 2022-03-31 was -$6.00K.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month |
|---|---|---|
| 2022-06-30 | -$115.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-11-17 | -$121.00K 10-Q/A · filed 2023-11-17 |
| 2022-03-31 | -$6.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |